| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.7 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.7 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.017 | 0.7 |